Remove venture-capital
article thumbnail

Regeneron launches $500m venture capital arm

pharmaphorum

Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.

article thumbnail

Venture Capital Shines Spotlight on Northern Ireland Life and Health Sciences

Fierce Pharma

Venture Capital Shines Spotlight on Northern Ireland Life and Health Sciences jpiatt Wed, 02/22/2023 - 10:10

181
181
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Venture Capital Firm Shares Ambitious Value-Based Care Strategy: Buy a Health System [Sponsored]

MedCity News

The opening day of the HLTH 2023 event offered a surprising announcement from venture capital firm General Catalyst. Weight Watchers CEO called for a change in how we talk about obesity. ENGAGE at HLTH offered compelling discussions around retail health, prescription drug prices and investment trends.

Retail 100
article thumbnail

Why Should U.S. Companies Consider Public Venture Capital? [Sponsored]

MedCity News

The MedCity INVEST conference included a panel discussion on raising public venture capital in Canada, sponsored by Cozen O’Connor and TSX.

80
article thumbnail

Nixon Gwilt Law Expands Corporate, M&A, and Venture Capital Capabilities with Four New Attorneys

Nixon Gwilt Law

Nixon Gwilt Law (NGL) is excited to announce a significant expansion of our core capabilities through the addition of four attorneys with expertise in healthcare mergers and acquisitions , fundraising and venture capital , and corporate/business counsel. His experience spans venture capital, private equity, and public offerings.

article thumbnail

In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials

Fierce Pharma

Venture capital firms pitching in on drug development isn’t exactly a new way of doing business for the biopharma industry. Venture capital firms pitching in on drug development isn’t exactly a new way of doing business for the biopharma industry.

Biopharma 247
article thumbnail

15 Top Venture Capital for Biotech Companies

Medico Reach

Venture capital is the lifeblood of breakthrough medical technologies. Whether you are a start-up looking for investment or are interested in working in venture capital (VC), the worldwide biopharma and MedTech industries are growing. The ecosystem of biotech ventures peaked in 2021. The Venture Capitals.